0000950170-23-026809.txt : 20230607 0000950170-23-026809.hdr.sgml : 20230607 20230607160208 ACCESSION NUMBER: 0000950170-23-026809 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20230605 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing FILED AS OF DATE: 20230607 DATE AS OF CHANGE: 20230607 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Acer Therapeutics Inc. CENTRAL INDEX KEY: 0001069308 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320426967 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33004 FILM NUMBER: 23998959 BUSINESS ADDRESS: STREET 1: ONE GATEWAY CENTER (300 WASHINGTON ST.) STREET 2: SUITE 356 CITY: NEWTON STATE: MA ZIP: 02458 BUSINESS PHONE: (844) 902-6100 MAIL ADDRESS: STREET 1: ONE GATEWAY CENTER (300 WASHINGTON ST.) STREET 2: SUITE 356 CITY: NEWTON STATE: MA ZIP: 02458 FORMER COMPANY: FORMER CONFORMED NAME: Opexa Therapeutics, Inc. DATE OF NAME CHANGE: 20060616 FORMER COMPANY: FORMER CONFORMED NAME: PharmaFrontiers Corp. DATE OF NAME CHANGE: 20051011 FORMER COMPANY: FORMER CONFORMED NAME: PHARMAFRONTIERS CORP DATE OF NAME CHANGE: 20040816 8-K 1 acer-20230605.htm 8-K 8-K
0001069308false00010693082023-06-052023-06-05

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): June 5, 2023

ACER THERAPEUTICS INC.

(Exact name of registrant as specified in its charter)

 

Delaware

001-33004

32-0426967

(State or other jurisdiction of
incorporation)

(Commission File Number)

(IRS Employer Identification No.)

 

One Gateway Center, Suite 356
300 Washington Street

Newton, Massachusetts

02458

(Address of principal executive offices)

(Zip Code)

 

Registrant’s telephone number, including area code: (844) 902-6100

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

Trading Symbol

  Name of Each Exchange on Which Registered

Common Stock, $0.0001 par value per share

ACER

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

Item 3.01. Notice of Delisting or Failure to Satisfy Continued Listing Rule or Standard; Transfer of Listing.

Nasdaq Bid Price Deficiency Notice

On June 5, 2023, Acer Therapeutics Inc. (the “Company”) received a letter (the “Bid Price Deficiency Notice”) from the listing qualifications department staff of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company is not in compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market (the “Bid Price Requirement”).

The Bid Price Deficiency Notice has no immediate effect on the listing of the Company’s common stock, and the Company’s common stock continues to trade on the Nasdaq Capital Market under the symbol “ACER.”

In accordance with Nasdaq listing rule 5810(c)(3)(A), the Company has 180 calendar days from the date of the Bid Price Deficiency Notice, or until December 4, 2023, to regain compliance with respect to the Bid Price Requirement. The Bid Price Deficiency Notice states that to regain compliance with the Bid Price Requirement, the closing bid price of the Company’s common stock must meet or exceed $1.00 per share for a minimum of ten consecutive business days during the compliance period ending December 4, 2023.

If the Company fails to regain compliance with the Bid Price Requirement by December 4, 2023, the Company may be eligible for an additional 180-day compliance period to demonstrate compliance with the Bid Price Requirement. To qualify, the Company will be required to meet the continued listing requirement for market value of publicly held shares (see the disclosure below under the heading “Prior Nasdaq MVLS Notice”) and all other initial listing standards for The Nasdaq Capital Market, with the exception of the Bid Price Requirement, and will need to provide written notice to Nasdaq of its intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary. If the Company does not qualify for the second compliance period or fails to regain compliance with the Bid Price Requirement during the second 180-day period, Nasdaq will notify the Company of its determination to delist the common stock, at which point the Company would have an opportunity to appeal the delisting determination to a Hearings Panel.

The Company intends to actively monitor the closing bid price of the Company’s common stock between now and December 4, 2023 and may, if appropriate, evaluate available options to resolve the deficiency and regain compliance with the Bid Price Requirement. While the Company is exercising diligent efforts to maintain the listing of its common stock on Nasdaq, there can be no assurance that the Company will be able to regain or maintain compliance with Nasdaq listing standards.

Prior Nasdaq MVLS Deficiency Notice

Separately, and as previously disclosed, on May 3, 2023, the Company received a letter (the “MVLS Deficiency Notice”) from the listing qualifications department staff of Nasdaq notifying the Company that for the 30 consecutive business days prior to the date of the MVLS Deficiency Notice, the Company’s minimum Market Value of Listed Securities (“MVLS”) was below the minimum of $35 million required for continued listing on the Nasdaq Capital Market pursuant to Nasdaq listing rule 5550(b)(2).

The MVLS Deficiency Notice had no immediate effect on the listing of the Company’s common stock, and the Company’s common stock continues to trade on the Nasdaq Capital Market.

In accordance with Nasdaq listing rule 5810(c)(3)(C), the Company was provided 180 calendar days from the date of the MVLS Deficiency Notice, or until October 30, 2023, to regain compliance with respect to the MVLS requirement. The MVLS Deficiency Notice stated that to regain compliance, the Company’s MVLS must close at $35 million or more for a minimum of ten consecutive business days (or such longer period of time as the Nasdaq staff may require in some circumstances, but generally not more than 20 consecutive business days) during the compliance period ending October 30, 2023. The Company believes that it can also regain compliance relative to the MVLS requirement by meeting a continued listing standard of a minimum stockholders’ equity of at least $2.5 million.

If the Company does not regain compliance with respect to the MVLS requirement by October 30, 2023, Nasdaq staff will provide written notice to the Company that its securities are subject to delisting. At that time, the Company may appeal any such delisting determination to a Hearings Panel.

The Company intends to actively monitor the Company’s MVLS between now and October 30, 2023 and may, if appropriate, evaluate available options to resolve the deficiency and regain compliance with respect to the MVLS requirement. While the

2

 

Company is exercising diligent efforts to maintain the listing of its common stock on Nasdaq, there can be no assurance that the Company will be able to regain or maintain compliance with Nasdaq listing standards.

 

3

 

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: June 7, 2023

ACER THERAPEUTICS INC.

By:

/s/ Harry S. Palmin

Harry S. Palmin

Chief Financial Officer

 

 

4

 

 EX-101.SCH 2 acer-20230605.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 100000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 acer-20230605_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Address, State or Province Entity Address, State or Province Trading Symbol Trading Symbol Soliciting Material Soliciting Material Entity Address, City or Town Entity Address, City or Town Written Communications Written Communications Entity Central Index Key Entity Central Index Key Entity Tax Identification Number Entity Tax Identification Number Entity Registrant Name Entity Registrant Name Entity Address, Address Line Three Entity Address, Address Line Three Document Period End Date Document Period End Date Entity Address, Postal Zip Code Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Local Phone Number Local Phone Number City Area Code City Area Code Pre-commencement Tender Offer Pre-commencement Tender Offer Cover [Abstract] Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Amendment Flag Amendment Flag Entity File Number Securities Act File Number Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, Address Line One Entity Address, Address Line One Title of 12(b) Security Title of 12(b) Security Document Type Document Type EX-101.PRE 4 acer-20230605_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 5 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Document and Entity Information
Jun. 05, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Entity Central Index Key 0001069308
Document Period End Date Jun. 05, 2023
Entity Registrant Name ACER THERAPEUTICS INC.
Entity Incorporation, State or Country Code DE
Entity File Number 001-33004
Entity Tax Identification Number 32-0426967
Entity Address, Address Line One One Gateway Center
Entity Address, Address Line Two Suite 356
Entity Address, Address Line Three 300 Washington Street
Entity Address, City or Town Newton
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02458
City Area Code 844
Local Phone Number 902-6100
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.0001 par value per share
Trading Symbol ACER
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 6 acer-20230605_htm.xml IDEA: XBRL DOCUMENT 0001069308 2023-06-05 2023-06-05 0001069308 false 8-K 2023-06-05 ACER THERAPEUTICS INC. DE 001-33004 32-0426967 One Gateway Center Suite 356 300 Washington Street Newton MA 02458 844 902-6100 false false false false Common Stock, $0.0001 par value per share ACER NASDAQ false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 1 24 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.acertx.com/20230605/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports acer-20230605.htm acer-20230605.xsd acer-20230605_lab.xml acer-20230605_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "acer-20230605.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 24 }, "contextCount": 1, "dts": { "inline": { "local": [ "acer-20230605.htm" ] }, "labelLink": { "local": [ "acer-20230605_lab.xml" ] }, "presentationLink": { "local": [ "acer-20230605_pre.xml" ] }, "schema": { "local": [ "acer-20230605.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 25, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2023": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 24, "memberCustom": 0, "memberStandard": 0, "nsprefix": "acer", "nsuri": "http://www.acertx.com/20230605", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "acer-20230605.htm", "contextRef": "C_e0835d8c-c47d-44d3-920a-99e94e375db8", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "menuCat": "Cover", "order": "1", "role": "http://www.acertx.com/20230605/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "acer-20230605.htm", "contextRef": "C_e0835d8c-c47d-44d3-920a-99e94e375db8", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.acertx.com/20230605/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.acertx.com/20230605/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.acertx.com/20230605/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.acertx.com/20230605/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.acertx.com/20230605/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.acertx.com/20230605/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three", "terseLabel": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.acertx.com/20230605/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.acertx.com/20230605/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.acertx.com/20230605/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.acertx.com/20230605/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.acertx.com/20230605/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.acertx.com/20230605/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Securities Act File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.acertx.com/20230605/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.acertx.com/20230605/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.acertx.com/20230605/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.acertx.com/20230605/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.acertx.com/20230605/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.acertx.com/20230605/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.acertx.com/20230605/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.acertx.com/20230605/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.acertx.com/20230605/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.acertx.com/20230605/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.acertx.com/20230605/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.acertx.com/20230605/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 13 0000950170-23-026809-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-23-026809-xbrl.zip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

BM%RN2\1H:,Z<:U?Y?Z37;]9.;9'8AWZ4_2QZIW8CWO1D*6QO=L-[=!^]> M8&.Z-TD^#M@UE"$D92&RML/B$1OG1WNDW9!MI6I^G]9YNV*VYDLV;-9H%= G M9DO36_]UGA815TGT#Q"C,5+/!&?D(XOB80;*$E0/#7=3:3B&:"<^5>V4\X^- M+RM3&4B]7I7WVZY'+BW>#5#ZL[+[HL4*- M5ZU&9A^DMQHEI1L:,5FO0_FALM5/>DO3")(QZ@_[), 5#=2*,OAC&&7E6;X< MAT8W%N_ 3JIYS0",;=L:^J#[QD'E[M8P-(&K9'I-73:0"C-9U7*:7MS-8++0 MUBZ> &P4>D.9T'OT305G24JB?A^$JL,!80@RIY7,*%\5);!_(V#+%%'K-H\H01E<,V6@'0&^4 *LI2QF0&F\+%%UJF'>O%$ M7AF'E6.M'*"D!X_37-+KSDH\1)U(?Y@7I ^H 4@ N.6 AJ$T.Y.M;64VV,0, MR6[58_5)7A?/#H8XM"RNK6@OAEEIZV!Z#57&!7DD+\X3N;$=/RX$S(@I"3%R MRA^C!C)%N$1WI[KNLS$)T/@@^2)YFEW)=2(+IZFD(!H#!!**,KQ$;G%" E!M M9+JQ@(?/"K4_K;S*\>QL1E$V(RP4,C=:3_0N,2JGN=*S/+PCG(2=P70)K14P)\=55$N@ M)%>5>26CJM1'4N(I7JF&Q/ZBHBKII0; 2US%Y9(F=T \!5D(:FDBED@ BE?I MMJABQS(Y#%D.%8SFV+A0I?<2%,$\9]FX-2_9(H72VZ_$0='GWB%E<;]'J\/B MFFKI+GL_K(E4DA1)5U4VJ^=;$4\ QE:HO:PFH%")CAK?ISVS@HS4P<%!&B6S M<078')).?G*$H@; MD_'#FHRKZ0A:E>M3*L*X]$80 E$FHZ)2KD?Z10$4(U"0,E*X,V]9U(]H4)3. M3Y48/"0@(5G:"':#NJL>FTH'93I!J7&>QC<+ "1[^UX-;\ECNC',YQ/@%C(> MJ36+"-DNL0"!"Q5.3:"/8Q1RG+G(2ZKZ# 72.IV@S!9B)D>A07N%@1S+T9*H M&2XD-&JKIM9]!UO*8%4#SR]PSN&?V(^WI>!-BO;Q*=I%EZ3)T3YW-:#J"^],TN:/ M",E>^NNR_ZD(_"?3QJ]Q+'VC20"Q,KV[.NTU?61A:>)%)H\#F3S>'31N_*UG M2.\NEWOTZ,669W8?M'_:2,.SYFR[) [P/>2NM]I1BE$929L&JM%#N=YY1K9EX#LU=!#=U.CPJ5-C!XGP9+S.(F9K% M"C[*G(U,J949FT736(<:DEYW1%\X_(3@N5$\%9Q2#?J/"3T9KP MKT&99TX+3Y)GC]-H*0F+ #&C%RIR79U17/ C9<"ER(_)@#5"MSE'YZ%YI>4 /Y\VFI>YETL;K35QD^31 MSCCVVW$,]C7?([11>AK-2=I7/$G;8.[D"?LF<_V#0^I;4NS&OM1$-;>#GMLI M7(VQ;73RQ9];N3S[^?SDZK>+TZT)'/\SS.5&S1M NZ]3.RGELZF36"M_X+/] MA\L>:A5###PY&^8JYQCEU8L\Y3#HK.1(1+R 'H_T@@+HL3B4N0[9D3KB53:H M'*%A(C,3LD,V+'IIAE00.^NK;&-%6LMO>=:Z6K,M'-(P\G&,;!C4,*AA4,.@ M-\R@^VR5\1JVJHK&*F*;LP6"#-L^K/]#BC9,WW*MW&%F[F (\8_QTM>*O!*W M]975O1[,::/A]').M_/VZY6,6\ST;@*?=IPCO[ L&Y/+%OG*8FRSBYG4UP:, MG3(/.\/,)AGQ1AC9,*AA4)-O?VZ#W6C<#FE<8]O>"",;!C4,VDH&[:!AZ_8B M",G'2:'Z+V$8<<@:KNZ@VFW1N\A7',_[8<^!-H=BW^)!=6L[Z+F=PO70@^K' M[2 5X_=_.F[WBG[\_O\!4$L#!!0 ( $. QU8&$SK>"0, )D) 1 M86-EO./*T"9P?[09:M&X:E$F5RD M M2+PA-[EV%HX=;&=M_WOL).[2K2W;D.A+G;OO[OO.=W9R?KDJ.-RATDR*09"$ M<0 H,IDSL1@$WZ?D:OIQ- HN+UZ=OR8$AM>C&[C!)5QEAMWAD.F,2UTIA*/I MYV/X\6$RAFEVBP6%HM>$ M.VU_%]M@;;E;T&6_I8J3Z,?G<=--#^9,_-I"=Z3%_:+"@M-Q%S MJF/ M"FRW(SD[.XMJ;W#Q"J >$E:44AEH9F4LL[H/!\C<$_&,Q)E(TB/])+3) A [ MIVR/W.C?1/@^O4C$ILDO%>&;Y-A/]_'N[.J3&/6^^7$+XA8'.1]-W?-(=XYX MA-QH;SDH8?<)N9= A9"FYG4F;RQ+)N:RL5B;ZU#JVS3!.=2#FU*5*7$'^+_.1T%MJSXR&/"+9GQ[DC&X)\?"_/QQIF M7/#8N3749\U[UJ5U:+O_O!V[_UYGJ?"Y==H0;6_ZNEO[R_W:03VY:)?_F_6# M6WR?C/YVV4>&KJ20Q;I1YM_-_O]*Y)^$U;,>V3%21:TE &9?#$]">FU>78[V M+<_J(4UB][/? )W/@L-?H>M0G!26T/G/#>6YG:Y^ -02P,$% @ 0X#'5AL^ M)LYR!@ IT< !4 !A8V5R+3(P,C,P-C U7VQA8BYX;6S57&V/VC@0_MY? M,<=]:74-(>%>5-3=BF-W*W3[IH7JJCN=JI 8B&IBY(0%_OW9>2LF3F +L=-/ MS9+)XV?&;^,93]]_V"PP/",:^B2X:%GM3@M0X!+/#V87K4\CHS\:#(>M#Y>O MWO]D&'!U,[R'>[2&OAOYS^C*#UU,PA5%\'IT]P8^__ET"[=^\'7BA BNB+M: MH" " ^91M.R9YGJ];GM3/P@)7D6LP;#MDH4)AI'"#RAR^.]PY40(>G;'[AJ= MWXW.'V/+[MEVK_MKV[9^Z_[2Z?0ZG9W/R')+_=D\@M?N&^!?L;:# &&\A1L_ M< +7=S",LD;?PC!PV]#'&)[X5R$\H1#19^2U$TS,-.CA3(U-Z/="=XX6SBUQ M8WH7K1U]-A.*VX3.3+O3Z9KY5Z42_"\C$S/X3X9E&UVKO0F]%K#>",*X[2,: MR<0W!?EU-Y:VWKU[9\9O<]'0EPDR6,O\?'<[BO4T6 ]%S&JH=?D*(#6',T&8 M=RW$>#U*,*J@R%^;:<.Q?.1'_(,<)O]]NV0_HTV$ @]Y<8-YD\05A# W/Z'9 MEW.*I@F#D%&(FP^1VYZ19]-#OLF' 7\P^ ,W[L_LCR^/% W(@HU*%_&A.0S# M%:)CWC9]F$Y1#A[SO&@=]8E9-^GK@%EOV_<\BL)P%+&Y\4 ?*7GV>1<5"5>* MUTYV3!V^>(RVBPG!$G;B^]KIL%GONW[$6KQCAJ!L(9!PD@BI[=0!>WR@8[(. M#O7GCF3M%/^F?L3F)1_]J\!/UKY00E NI\B" S8GJ8.';#YN_D+;4OOMRRFB M-W8V0X\U[4]3P]RO%A/I.E,MKXCN$YKY(;-3$-T[B_+%94],[61)_V&[".H> MFBZ";.TT,X_GD:TAQ+L./.['2"C*Y=1:\9&P/1[_XR\'Q#NXBXC"BH@R+XW0 M):'Q-(CWL0%9L4F\K61<_57MU+F/B!_G)$"E$[T@4CLIOFGTF6]=8CCA=>UD M]ORI%SE?2MVN 6'GHOZ$KW-N)#.;\+Y^3P:Y*[;1;J\W[MP)9JAD@9:**9JQ MUPM$9\R+^DC).IJSCELZ0?F.+)>NG6J?#22/#Z8;[,PDY,3WBBQWX^/R!:,@ MHFV_M5^PW]KZ:%HOH&FIF[F6/1GS8W#%K,U%E/DJ8X98X:+$KT4R7(B'$]@3 M#Q*AP/@T$H_SS+9D1:6'TT.GZ2]XDI_0CHDQL.-:B&XY?NN281ON#C@DZ)# M0XS_WOS&J+E:8=T*5<403NFB!!=2X+<00P.AD($W7QVL51,A?')*3Z1 D" U MD"Q6Q[,8_SG%LM_0((-K*FVLF'%)*.N<*PI'Y=.0XS9:B9)UI'[^TG#=*5V0 M H*(V&#R6#UO:1#R#.,^1808$AAF@^EC??@CM73KDBSGL$E MR' A 884N?&J8'U:"*GE4[H@!P*.U$"R6!W/_>SX&88V!U,0^_A^SN)BXJ.0 M7\A715N2ZJ\O?K F#5?EJ.B!:BVLVCKD(5 0 ;=3.)8 ^?=.RIG"9AQH.91W0^.'639I^)U(8>Z67OL\4"3J83I M$G:*649&TGKZ^922Q9%5,1D#\H(;,L5[1BI4.::\)E/CX$42/2I(BVXRSL5; M&'I(EI?B9$Q++C0T8%@4"W2D(V+O-H >XI5E.QGM\CRZ3FN7%/.(MI9EH762 M/E#B(Y*ORMSJ5$)>^"-RE^0[&S U9>5 TLE9R!'J(5]9))01+\^J-<#BTM(A MJ5+N?]7%F?7N6I4%C6)JT5Y?%J/ M)2IXQR,;ZKT\K% M BC1M'NQT@;L@K*RJ$-^A]U \M:QY*T&K![[)53[*X<0OM+KW^T65NV[=7D8 M**:X&\QAAOYZ^2K[Q4_^HY?+_P%02P,$% @ 0X#'5HC9IRF[! #2T M !4 !A8V5R+3(P,C,P-C U7W!R92YX;6SM6EUOVS84?<^OX+27%JLL6QEDB;:)4J1 TK'\[W>IF*UE4\D"1&H&]262QL)"$LY[3;OD.PBSB,6'SGO-Y[/;'@^'0^71^< 71$:4RZ7 Z-WXYCWZ\OOH&ET3]G4:2HPN>+1,,%/(10NETJ[G MK5:K5CPC3'*Z5#"@;$4\\9#K;LP/! [U[OK_5C:=K0>8+A=Y%[Y'N!6,SABE=HRO"0A:1D**Q&?0#&K*H MA?J4HI'N)=$(2RP><-QZM$EA!EUJII%)TI71 B?A-8]R>CUG:S[95- 6%W,O M\/V.]ZU7*4+_<@W,U8_<=N!VVJU,Q@Z"U6 R'_L_#&+@V1Y^U]UFD E::J1RK_70#UQPKG!$\UO9W!R^2Q9G"+,9Q MKKGA2WE4 %'M@5P4I=*\)1#/G43BJ#7G#UZ,24Y=W^0ZYAK"CW\&'%[W_E0J M$4;*6*+A%-.>L]_N54W'"#@!BQ8VA>;*R?1AJ%@/=T7#N85-L;UR.H\>-8#Q M1$B'X!W9GWAMH67'U;9T]U@0#NX?ZVW[B34LXFI2;X3G1/LR4[=A8F-GA=5$ M#@XB+E(N\CUA#%L#'O EK.)ZP.-RKD_WJHGZ%:'X=IE,L2CEN06IB=0DS(8Q M>!J9D<>C^AF&9?B:Z/;C&,X$N;G F8#;I51MV!]&,W@!S>#'T>R\@&:G9IH# MN+T3$[YBSY'<0M9+,=]:[L2]X ]$1X//\-R%UTOVGD/,2O\FZ9-;IQ5<.5&] M@GW(;4JH%9HK)Z.S&'J_X*Q\^]Z#5$[J+T$4Q+\#GB1+MMF+I869'592L4PAQ-YM9E_4)<-U$AU(NL7@1 MW?TNU2\[CI;@<.MV,)WH',ZVZ+N0RDE-1*BK,^-U,N4V-RRVUZ;1918M0C;' M)5&V%5;3"7&98#$'2?X0?*46X%-IR,K3*#NZ0'4[D^^+(NU01,8TW.Y5%HJ5 MG W"2T,!]MQH06AL>L\$3VP9N1F-6Q)DQ 6\'3WG\%07\E)(M[3F/0?BM:4$ M(CS5E/7N!5. 5TC@^/IQ_J44:'#+)!J?CT_V#3H/_K?:<__!5!+ 0(4 Q0 ( $. QU:):4^:?!@ M /X& 0 1 " 0 !A8V5R+3(P,C,P-C U+FAT;5!+ 0(4 M Q0 ( $. QU8&$SK>"0, )D) 1 " :L8 !A8V5R M+3(P,C,P-C U+GAS9%!+ 0(4 Q0 ( $. QU8;/B;.<@8 *=' 5 M " >,; !A8V5R+3(P,C,P-C U7VQA8BYX;6Q02P$"% ,4 M" !#@,=6B-FG*;L$ -+0 %0 @ &((@ 86-E&UL4$L%!@ $ 0 ! $ '8G $! end